TY - JOUR
T1 - Cancer events in Belgian nursing home residents
T2 - An EORTC prospective cohort study
AU - Wildiers, Hans
AU - Mauer, Murielle
AU - Elseviers, Monique
AU - De Wolf, Jonas
AU - Hatse, Sigrid
AU - Hamaker, Marije
AU - Buntinx, Frank
AU - De Lepeleire, Jan
AU - Uytterschaut, Geert
AU - Falandry, Claire
AU - Tryfonidis, Konstantinus
AU - Janssen-Heijnen, Maryska
N1 - Funding Information:
This work was supported by Armonea.We thank Armonea for providing financial and logistical support for this study, and we thank all the nursing home residents and personnel (with special thanks to Linda Gyles, Carine Jacquet, and Sonja Sommeryns) for their participation and contribution. We thank Edith Bastiaens, Melanie Beauvois and Nabila Sebti from the EORTC datacenter for their support for the study conduct. This publication was supported by the EORTC Cancer Research Fund. We thank Françoise Meunier, former director general of EORTC, for making this study possible.
Funding Information:
This work was supported by Armonea .
Funding Information:
This work was supported by Armonea.We thank Armonea for providing financial and logistical support for this study, and we thank all the nursing home residents and personnel (with special thanks to Linda Gyles, Carine Jacquet, and Sonja Sommeryns) for their participation and contribution. We thank Edith Bastiaens, Melanie Beauvois and Nabila Sebti from the EORTC datacenter for their support for the study conduct. This publication was supported by the EORTC Cancer Research Fund. We thank Fran?oise Meunier, former director general of EORTC, for making this study possible.
Publisher Copyright:
© 2019
PY - 2019/9
Y1 - 2019/9
N2 - Objectives: This prospective multicenter cohort study aimed to describe new cancer events in nursing home residents (NHR).Materials and Methods: The study was performed in 39 nursing homes from the Armonea network in Belgium, covering 4262 nursing home beds. All NHR in these homes were prospectively followed during 1 year for occurrence of cancer events (diagnosis or clinical suspicion of a new cancer or progression of a known cancer). After training, each site's local staff identified NHR with cancer events in collaboration with the treating general practitioner (GP). NHR with cancer events were included after informed consent, and data about general health and cancer status were collected every 3 months up to 2 years.Results: In only nine NHR (median age 87 years, range 72-92), a cancer event was recorded during follow-up including five new (suspected or diagnosed) cancer events (incidence rate = 123/100.000 NHR per year) and four NHR with (suspected or diagnosed) progressive disease. In four NHR with suspected cancer, no diagnostic procedure was performed, and in five no anticancer treatment was started.Conclusion: Clinically relevant cancer events (potentially requiring diagnostic or therapeutic action) occur at a much lower frequency in NHR than expected from cancer incidence data in the general older population. Although some underreporting of cancer events cannot be excluded, this prospective study supports several previous retrospective observations that cancer events are rare in very frail older persons. Moreover, diagnostic and therapeutic actions for (suspected) cancer events are often not undertaken in this population. (C) 2019 Published by Elsevier Ltd.
AB - Objectives: This prospective multicenter cohort study aimed to describe new cancer events in nursing home residents (NHR).Materials and Methods: The study was performed in 39 nursing homes from the Armonea network in Belgium, covering 4262 nursing home beds. All NHR in these homes were prospectively followed during 1 year for occurrence of cancer events (diagnosis or clinical suspicion of a new cancer or progression of a known cancer). After training, each site's local staff identified NHR with cancer events in collaboration with the treating general practitioner (GP). NHR with cancer events were included after informed consent, and data about general health and cancer status were collected every 3 months up to 2 years.Results: In only nine NHR (median age 87 years, range 72-92), a cancer event was recorded during follow-up including five new (suspected or diagnosed) cancer events (incidence rate = 123/100.000 NHR per year) and four NHR with (suspected or diagnosed) progressive disease. In four NHR with suspected cancer, no diagnostic procedure was performed, and in five no anticancer treatment was started.Conclusion: Clinically relevant cancer events (potentially requiring diagnostic or therapeutic action) occur at a much lower frequency in NHR than expected from cancer incidence data in the general older population. Although some underreporting of cancer events cannot be excluded, this prospective study supports several previous retrospective observations that cancer events are rare in very frail older persons. Moreover, diagnostic and therapeutic actions for (suspected) cancer events are often not undertaken in this population. (C) 2019 Published by Elsevier Ltd.
KW - Cancer
KW - Nursing home
KW - Older
KW - Incidence
KW - PREVALENCE
KW - OLD
U2 - 10.1016/j.jgo.2019.03.005
DO - 10.1016/j.jgo.2019.03.005
M3 - Article
C2 - 30898534
SN - 1879-4068
VL - 10
SP - 805
EP - 810
JO - Journal of Geriatric Oncology
JF - Journal of Geriatric Oncology
IS - 5
ER -